Victoza and Pregnancy
In clinical studies on pregnant animals, Victoza (liraglutide) increased the risk of serious birth defects, miscarriage, and other problems. However, it is unclear if the same problems would occur in pregnant women. Your healthcare provider will consider the benefits and risks of using this medication in your particular situation before making a recommendation.
Victoza® (liraglutide) is a prescription medication approved to treat type 2 diabetes. It is not approved for the treatment of gestational diabetes. Animal studies suggest that this medication may not be safe for use during pregnancy.
What Is Pregnancy Category C?
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but do appear to cause harm to the fetus in animal studies.
In addition, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
When given to animals during pregnancy, Victoza slightly increased the risk of miscarriages and increased the risk of various major birth defects, lower newborn weight, and prolonged pregnancy (delayed birth).
However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category C medicine may be given to a pregnant woman if the healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child.
If you are pregnant or are thinking of becoming pregnant while taking this drug, let your healthcare provider know. He or she will consider Victoza's benefits and risks before making a recommendation in your particular situation. As a pregnant woman with diabetes, you will need more prenatal care than the average pregnant woman.